To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3331 | Mg2-1812 |
Novel potent negative allosteric modulator (NAM) of mGlu2
More description
|
|
| DCC3330 | Mfn103 |
Novel Dual Fluorescent and Magnetic Resonance False Neurotransmitter
More description
|
|
| DCC3329 | Metrizoate Calcium |
Radiographic Contrast Agent
More description
|
|
| DCC3328 | Metocurine |
Non-depolarizing muscle relaxant
More description
|
|
| DCC3327 | Metoclopramide Hydrochloride |
Dopamine D2 antagonist, antiemetic
More description
|
|
| DCC3326 | Met-in-3s |
Highly Selective Class II MET Inhibitor
More description
|
|
| DCC3325 | Methylnaltrexone Iodide |
Peripherally restricted μ-opioid antagonist
More description
|
|
| DCC3324 | Methylhonokiol |
Novel Class of Cannabinoid CB2 Receptor Inverse Agonist
More description
|
|
| DCC3323 | Methylene Quinuclidinone |
Metablite of PRIMA-1 and APR-246, covalently binding to cysteine residues in mutant p53 and wild type p53, and being increased in unfolded p53, inducing massive apoptosis in p53 null tumor cells
More description
|
|
| DCC3321 | Methyl Streptonigrin |
Novel inhibitor of ABCG2 transporter function
More description
|
|
| DCC3320 | Methyl Meso-(meta-pyridinium) Bodipy |
Novel photosensitizer as a photodynamic antimicrobial agent against Staphylococcus aureus, Escherichia coli, Candida albicans, and Methicillin-resistant S. aureus (MRSA)
More description
|
|
| DCC3319 | Methyl 6-bromo-1h-indazole-4-carboxylate |
Useful pharmaceutical building block
More description
|
|
| DCC3318 | Methoxyluteolin |
Inhibitor of pro-inflammatory mediator release from mast cells
More description
|
|
| DCC3317 | Methoxybrassinin |
Natural potent anti-proliferative agent, inducing apoptotic cell death
More description
|
|
| DCC3316 | Methocinnamox |
Potent, long-lasting, and selective antagonist of morphine-mediated antinociception
More description
|
|
| DCC3315 | Metamizole |
Cyclooxygenase 3 (COX3) inhibitor, acting as a potent inductor of cytochrome P450 isoenzymes CYP2B6 and CYP3A4
More description
|
|
| DCC3314 | Metabolex-36 |
Novel selective GPR120 agonist
More description
|
|
| DCC3313 | Mesyl Salvinorin B |
Novel selective and potent full KOP receptor agonist with fewer side effects (e.g., sedation or anhedonia) than classic KOP receptor
More description
|
|
| DCC3312 | Mesterolone |
Anabolic and androgenic agent
More description
|
|
| DCC3311 | Meso-dihydroguaiaretic Acid |
LXR-α antagonist, inhibiting hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells
More description
|
|
| DCC3310 | Merodantoin |
Apoptosis inducer, triggering ROS dependent autophagy-associated apoptosis in a variety of human cancer cell lines and against mutant KRAS expressing cancer cells involving AKT-dependent ROS production
More description
|
|
| DCC3309 | Meriolin 5 |
Potent cell-permeable, ATP site-targeting inhibitor of CDKs
More description
|
|
| DCC3308 | Meriolin 3 |
Potent cell-permeable, ATP site-targeting inhibitor of CDKs
More description
|
|
| DCC3307 | meridianin A |
Novel Cell Death-Inducing Kinase Inhibitor with Enhanced Selectivity for Cyclin-Dependent Kinases; Antimalarial
More description
|
|
| DCC3306 | Men16132 |
Novel potent and selective nonpeptide kinin B2 receptor antagonist
More description
|
|
| DCC3305 | Melperone Hydrochloride |
5-HT2A/D2 receptor antagonist
More description
|
|
| DCC3304 | Melogliptin |
Potent, selective and orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4)
More description
|
|
| DCC3303 | Melk-in-c1 |
Novel Multi-Kinase Inhibitor, Triggering Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition
More description
|
|
| DCC3302 | Melinamide |
Inhibitor of cholesterol esterification
More description
|
|
| DCC3301 | Melarsoprol |
Prodrug of melarsen oxide (Mel Ox), irreversibly binding to vicinal sulfhydryl groups on pyruvate kinase, disrupting energy production in the parasite
More description
|
|